Download Instead

Pharma Demand Forecasting

Pharmaceutical demand forecasting is challenged by market volatility, varying product life cycles, and global supply chain disruptions. Overcome the complexity of adopting new forecasting technologies and build more accurate, defensible forecasts for your products today.

Get in touch with our experts

Why Pharma Forecasting Remains Challenging

Despite significant investments in the forecasting process, accuracy and alignment remain major hurdles. One key challenge is the lack of reliable historical sales data, especially during new product launches. Miscalculating commercial demand for new medicines can cost companies up to $15 million per day in lost revenue.

Furthermore, the data required is often scattered across commercial, medical, market access, and supply chain teams. Without a unified framework for integrated real world data, inconsistencies thrive. Excessive reliance on manual adjustments and spreadsheets further complicates matters. These manual tweaks lack transparency and are difficult to track. Without a data-driven approach to navigate changing market dynamics, forecasts can become dangerously overly optimistic or conservative.

Working with epidemiological data enables us to understand the drivers of disease, helping us better predict market dynamics and market size. Unlike a more straightforward sales forecasting approach, our available data allows us to go deeper and gives us a stronger position to enable scenario planning. We assess multiple potential scenarios using a sophisticated model, which allows us to account for uncertainties, provide risk-adjusted estimates across markets, and provide a structured view of the resources needed for operations.

We take insights from doctors, patients and payers, coupled with quantitative modelling techniques to create more accurate forecasts that can account for treatment patterns, regulatory approvals and clinical outcomes. This strengthens our overall forecasting capabilities, improves accuracy, and allows us to evaluate not just the clinical potential of upcoming pharmaceutical products, but also the long-term commercial potential.

What Effective Pharma Demand Planning Looks Like

High-performing pharma organizations are revolutionizing demand planning by prioritizing transparency, integration, and flexibility. A successful forecasting model clearly articulates the underlying assumptions, enabling stakeholders to understand exactly how forecasts are generated.

These leaders integrate diverse sources of information, such as real world data, epidemiology, market dynamics, and competitor intelligence. Scenario planning has also become indispensable. It helps organizations prepare for uncertainty by modeling different demand outcomes and assessing the impact of supply chain interruptions and market competition. By continually monitoring and adjusting forecasts, teams can stay relevant as market dynamics evolve quickly.

Factoring the impact of market access into pharmaceutical forecasts helps to support decision-making beyond sales projections. Forecasts also inform pricing, determine affordability of drug products, how many patients will access the products and also demonstrate the value of treatments and therapies to payers. Using forecasts for market access can also demonstrate how treatments align with unmet needs, and what the potential impact on healthcare budgets could look like.

Our analytical approach to forecasting helps to inform decisions during the product development phase by showing where resources should be allocated, as well as planning drug launch potential, adoption rates and growth strategies. Ultimately, this contributes to solutions that achieve both patient impact and commercial success.

Pharma Forecasting Models and Approaches

Several forecasting models are utilized across the industry, each tailored to specific contexts:

Time-Series Forecasting

Time-series analysis techniques like Moving Average and ARIMA are used for products with stable, long-term sales data. This technique forecasts future demand based on trends and seasonality, though it struggles with new product launches.

Analogue-Based Forecasting

This method uses information from similar products to estimate demand. It is effective for pre-launch, provided the analogue and market data are of high quality.

Patient-Based Forecasting

Patient-based models use longitudinal data regarding epidemiology and treatment pathways to calculate demand based on disease prevalence, incidence, and compliance. This approach deeply considers patient behavior, patient preferences, and patient data, making it highly effective for specialty diseases and new launches.

Hybrid and Driver-Based Forecasting

The best methods for pharmaceutical demand forecasting involve a hybrid approach, combining epidemiology-based modeling with time-series statistical models. These allow forecasting teams to link key commercial drivers directly to outputs, proving effective in complex markets where multiple variables influence demand.

Choosing the Right Forecasting Approach

Selecting the right approach requires evaluating flexibility, transparency, and scenario capability. Models must accommodate different products, geographies, and varying regulatory environments. Integration with existing data systems ensures your forecasts rely on the most current and complete information, eliminating errors caused by fragmented data.

Addressing Common Concerns

Many organizations believe their current processes are sufficient, but even functional forecasts often lack the defensibility required in complex environments. Teams frequently face pushback from leadership when underlying assumptions are not documented.

While uncertainty is inherent—especially with new launches—modern forecasting tools manage this through robust data integration techniques. Modern tools have removed much of the historical complexity by streamlining data inputs and simplifying calculations. Explainability is no longer a luxury; it is a necessity for making forecasting an accepted strategic tool rather than a constant debating point.

Turn Forecasting Into a Strategic Advantage

Rosenblatt Life Science Consultants provides tailored forecasting services to pharmaceutical and life science businesses, accounting for the unique dynamics of every single product, indication and market. We work with clients across all stages of the lifecycle, whether they have assets still in early development or require assistance for in-market products.

Forecasting can be complicated and resource intensive, so we aim to streamline the process. We combine commercial insights, therapeutic expertise, and cutting-edge forecasting software, we deliver forecasts that allow our clients to better manage risk, find opportunities and realise the full potential of their pharmaceutical products.

Request a consultation >

FAQ

The future is increasingly data-driven, collaborative, and technology-enabled. Accurate forecasting now relies heavily on advanced statistical methods and machine learning models to enhance accuracy, responsiveness, and adaptability in predicting market trends.

Machine Learning algorithms like Random Forest and Support Vector Machines are used to detect complex patterns that traditional models miss. Leveraging advanced techniques such as Monte Carlo simulations allows for a probabilistically driven spectrum of possible outcomes. AI can help continuously refine the scenarios being modeled, providing timely insights and ensuring forecasts stay actionable.

Interestingly, outsourcing forecasting and data analytics has become a common practice among global pharmaceutical companies, with India emerging as a leading hub. Handling over 40% of the global outsourced data analytics in this sector, India’s growth in this area provides valuable insights to pharmaceutical companies while fueling significant job creation.

Pharmaceutical demand forecasting is the systematic estimation of the actual demand for pharmaceutical products across different markets, channels, and time periods. It is the critical foundation upon which your commercial strategy and daily business operations are built.

Unlike other industries, pharma demand forecasting deals with a high degree of uncertainty stemming from regulatory approvals, pricing, reimbursement, and competitor activities. A reliable framework minimizes these risks. Accurate demand forecasting ensures the timely availability of essential medicines to patients—preventing life-threatening shortages – while avoiding overproduction, expired stock, and financial losses. It acts as the primary driver for almost all operational decisions within the pharmaceutical supply chain, guiding marketing, sales, capacity utilization, and pricing strategies.

Improving forecast performance starts with clearly defining your objectives—including the purpose, required accuracy, and time horizon.

Cross-functional collaboration is essential for improving demand forecasting accuracy in pharmaceuticals. A structured Sales and Operations Planning (S&OP) process helps facilitate alignment between commercial, finance, supply chain, and market access teams, avoiding conflicting projections.

Moving toward driver-based forecasting makes assumptions explicit. Integrating a wide variety of high-quality data—from internal commercial sales data to external market intelligence—improves reliability. Scenario planning then allows you to evaluate the impact of strategic shifts and market changes.

Forecasting processes often fail due to excessive dependency on manual spreadsheets, which lack transparency and are hard to audit. Unstated assumptions destroy trust, especially when presenting real world sales numbers to finance teams or leadership.

Static models that are not frequently updated fail to cope with unexpected competitor launches or regulatory shifts. Conversely, models that are overly complicated attempt to cover all eventualities but become unmanageable. Clear, collaborative, and adaptable frameworks are the only way forward.